Bright Minds Biosciences (DRUG) Common Equity (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Common Equity of $222.51 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 494.9% from $37.41 million a year earlier but down 1.1% from the prior quarter.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Bright Minds Biosciences posted Common Equity of $58.7 million.
- Common Equity has a five-year compound annual growth rate of 155.2% (FY2020 to FY2025).
- By fiscal year, Common Equity came in at $4.07 million in FY2024 (-16.8%), $4.89 million in FY2023 (-40.7%), $8.26 million in FY2022 (-46.2%) and $15.35 million in FY2021.
- Five-year quarterly Common Equity spans a low of $4.06 million in fiscal Q4 2024 and a high of $224.98 million in fiscal Q2 2026.
- Year over year, Common Equity has now increased in each of the last three quarters, with growth averaging 486.4% over the last seven quarters.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2025 (growth of 834.1%); the low point was fiscal Q3 2022 (a decline of 62.9%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $224.98 million (Q2 2026), $64.02 million (Q1 2026) and $59.62 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Bright Minds Biosciences | 343.90 Mn | -219.69 Mn | - | 216.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 216.62 Mn |
| Mar 31, 2026 | 221.51 Mn |
| Dec 31, 2025 | 65.19 Mn |
| Sep 30, 2025 | 58.96 Mn |
| Jun 30, 2025 | 65.72 Mn |
| Mar 31, 2025 | 62.82 Mn |
| Dec 31, 2024 | 62.04 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 25.58 Mn |
| Mar 31, 2024 | 25.89 Mn |
| Dec 31, 2023 | 26.49 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 25.60 Mn |
| Mar 31, 2023 | 25.08 Mn |
| Dec 31, 2022 | 24.85 Mn |
| Sep 30, 2022 | 7.71 Mn |
| Jun 30, 2022 | 21.10 Mn |
| Mar 31, 2022 | 21.76 Mn |
| Dec 31, 2021 | 21.33 Mn |
| Sep 30, 2021 | 21.23 Mn |
API Access
Bright Minds Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();